Funding for this research was provided by:
Austrian Science Fund (KLI 139-B00)
Received: 23 September 2019
Accepted: 4 December 2019
First Online: 12 December 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethics Committee of the Medical University of Vienna, reference number: 1031/2011) and with the 1964 Helsinki declaration and its amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Dr. Preusser reports personal fees from Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome., grants from Böhringer-Ingelheim, Bristol-Myers Squibb, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie., outside the submitted work. Dr. Müller reports grants from Austrian Science Fund during the conduct of the study. The other authors declare that they have no competing interests.